top of page
PRESS
Closings of Series C Financing Round
San Francisco, May 31, 2023 - Recardio Inc., a late stage clinical stage life science company developing therapies for cardiovascular and...
May 30, 20232 min read
Recardio at BIO International Convention 2023
San Francisco, May 2, 2023 - Recardio Inc., a clinical-stage life science company focusing on regenerative therapies for cardiovascular...
May 1, 20231 min read
Recardio at J.P. Morgan Conference 2023
San Francisco, January 9, 2023 - Recardio Inc., a late-stage clinical-stage life science company focusing on therapies for cardiovascular...
Jan 9, 20231 min read
bottom of page